MediVas

MediVas is a biotechnology company that specialized in the development of biodegradable polymer technologies for controlled drug delivery and medical device coatings. The company's core platform is based on synthetic Polyesteramides (PEAs), which are derived from naturally occurring amino acids, offering high biocompatibility and tunable degradation profiles. MediVas collaborated with major pharmaceutical and medical device firms, including Pfizer and Guidant, to develop drug-eluting stents and sustained-release ophthalmic formulations. The company's intellectual property and PEA technology were eventually acquired by DSM Biomedical, where the platform continues to be utilized for advanced biomaterial applications.